Growing community of inventors

Labege, France

Simon Leiris

Average Co-Inventor Count = 4.05

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 2

Simon LeirisDavid Thomas Davies (6 patents)Simon LeirisMartin Everett (4 patents)Simon LeirisNicolas Sprynski (4 patents)Simon LeirisThomas David Pallin (3 patents)Simon LeirisDavid Edward Clark (3 patents)Simon LeirisRichard Leonard Elliott (3 patents)Simon LeirisToby Jonathan Blench (3 patents)Simon LeirisLilha Beyria (3 patents)Simon LeirisAndrew Peter Cridland (3 patents)Simon LeirisMagdalena Zalacain (1 patent)Simon LeirisJonathan Mark Sutton (1 patent)Simon LeirisMichael Steven Bodnarchuk (1 patent)Simon LeirisSimon Leiris (6 patents)David Thomas DaviesDavid Thomas Davies (7 patents)Martin EverettMartin Everett (4 patents)Nicolas SprynskiNicolas Sprynski (4 patents)Thomas David PallinThomas David Pallin (30 patents)David Edward ClarkDavid Edward Clark (26 patents)Richard Leonard ElliottRichard Leonard Elliott (16 patents)Toby Jonathan BlenchToby Jonathan Blench (11 patents)Lilha BeyriaLilha Beyria (3 patents)Andrew Peter CridlandAndrew Peter Cridland (3 patents)Magdalena ZalacainMagdalena Zalacain (45 patents)Jonathan Mark SuttonJonathan Mark Sutton (33 patents)Michael Steven BodnarchukMichael Steven Bodnarchuk (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Antabio Sas (6 from 7 patents)


6 patents:

1. 12378244 - Diazabicyclooctanones as inhibitors of serine β-lactamases

2. 12286411 - Indane derivatives for use in the treatment of bacterial infection

3. 12247013 - Indane derivatives for use in the treatment of bacterial infection

4. 11905286 - Diazabicyclooctanones as inhibitors of serine beta-lactamases

5. 11299467 - Chemical compounds

6. 11000511 - Chemical compounds as antibiotics

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/25/2025
Loading…